Literature DB >> 10787363

Determining the quality of breast cancer care: do tumor registries measure up?

N A Bickell1, M R Chassin.   

Abstract

BACKGROUND: Hospital tumor registries, which provide data that inform health services research and cancer control policies, may be a source of information about quality of cancer care. However, the accuracy of data from such registries is unknown.
OBJECTIVE: To determine the accuracy of tumor registry data by comparing it with data collected from numerous sources for a breast cancer quality improvement project.
DESIGN: Retrospective cohort study.
SETTING: Three teaching hospitals with tumor registries in the New York metropolitan area that had participated in the quality improvement project. PATIENTS: All women with newly diagnosed primary breast cancer (stage I or stage II) who were surgically treated at the study hospitals between 1 November 1994 and 31 August 1996. MEASUREMENTS: Sensitivity and specificity were calculated, and data from the quality improvement project were used as the gold standard.
RESULTS: The tumor registries and the quality improvement project had similar information on tumor stage and surgery type. Sensitivity ranged from 0.91 to 0.96, and specificity ranged from 0.93 to 0.97. When both sources were used to calculate quality measures, the overall rate of radiation therapy after breast-conserving surgery was 80% in the quality improvement project and 48% in the tumor registries (sensitivity, 0.58; specificity, 0.94). For receipt of adjuvant systemic treatment, the rate was 78% in the quality improvement project and 22% in the tumor registries (sensitivity, 0.27; specificity, 0.97).
CONCLUSIONS: Data from tumor registries provide accurate measures for hospital-based surgical treatments but not for outpatient treatments. Unverified tumor registry data should not be used to measure quality of care.

Entities:  

Mesh:

Year:  2000        PMID: 10787363     DOI: 10.7326/0003-4819-132-9-200005020-00004

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  26 in total

1.  Using routine comparative data to assess the quality of health care: understanding and avoiding common pitfalls.

Authors:  A E Powell; H T O Davies; R G Thomson
Journal:  Qual Saf Health Care       Date:  2003-04

2.  The roles of teaching hospitals, insurance status, and race/ethnicity in receipt of adjuvant therapy for regional-stage breast cancer in Florida.

Authors:  Lisa C Richardson; Lili Tian; Lydia Voti; Abraham G Hartzema; Isildinha Reis; Lora E Fleming; Jill Mackinnon
Journal:  Am J Public Health       Date:  2005-11-29       Impact factor: 9.308

3.  Patterns and correlates of adjuvant radiotherapy receipt after lumpectomy and after mastectomy for breast cancer.

Authors:  Reshma Jagsi; Paul Abrahamse; Monica Morrow; Sarah T Hawley; Jennifer J Griggs; John J Graff; Ann S Hamilton; Steven J Katz
Journal:  J Clin Oncol       Date:  2010-03-29       Impact factor: 44.544

4.  Information on chemotherapy and hormone therapy from tumor registry had moderate agreement with chart reviews.

Authors:  Xianglin L Du; Charles R Key; Lois Dickie; Ronald Darling; George L Delclos; Kim Waller; Dong Zhang
Journal:  J Clin Epidemiol       Date:  2005-09-30       Impact factor: 6.437

5.  Effect of the Pay-for-Performance Program for Breast Cancer Care in Taiwan.

Authors:  Raymond N C Kuo; Kuo-Piao Chung; Mei-Shu Lai
Journal:  J Oncol Pract       Date:  2011-05       Impact factor: 3.840

6.  Tumor registry versus physician medical record review: a direct comparison of patients with pancreatic neuroendocrine tumors.

Authors:  Elisabet E Manasanch; Jillian K Smith; Andreea Bodnari; Jeannine McKinney; Catherine Gray; Theodore P McDade; Jennifer F Tseng
Journal:  J Oncol Pract       Date:  2011-03       Impact factor: 3.840

7.  Quantifying limitations in chemotherapy data in administrative health databases: implications for measuring the quality of colorectal cancer care.

Authors:  Robin Urquhart; Daniel Rayson; Geoffrey A Porter; Eva Grunfeld
Journal:  Healthc Policy       Date:  2011-08

8.  Building better oncology data systems and workforce models in a rapidly changing health care system.

Authors:  Erin P Fraher; Karyn B Stitzenberg
Journal:  J Oncol Pract       Date:  2013-01       Impact factor: 3.840

9.  Receipt of adjuvant endometrial cancer treatment according to race: an NRG Oncology/Gynecologic Oncology Group 210 Study.

Authors:  Ashley S Felix; David E Cohn; Theodore M Brasky; Richard Zaino; Kay Park; David G Mutch; William T Creasman; Premal H Thaker; Joan L Walker; Richard G Moore; Shashikant B Lele; Saketh R Guntupalli; Levi S Downs; Christa I Nagel; John F Boggess; Michael L Pearl; Olga B Ioffe; Marcus E Randall; Louise A Brinton
Journal:  Am J Obstet Gynecol       Date:  2018-08-07       Impact factor: 8.661

10.  Combining information from cancer registry and medical records data to improve analyses of adjuvant cancer therapies.

Authors:  Yulei He; Alan M Zaslavsky
Journal:  Biometrics       Date:  2009-02-04       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.